Effects of glycerides on the intestinal absorption of cyclosporine A using the in-situ mesenteric vein cannulated rat model

Current Drug Delivery

Volumn 2, Issue 3, 2005, Pages 289-294

  Ghorab, Mamdouh M ^a   Abdel Salam, Heba M ^b   Abdel Moate, Mohamed M ^b  

^a SUEZ CANAL UNIVERSITY   (Egypt)

^b Medical Union Pharmaceutical Co   (Egypt)

Author keywords

Absorption enhancers; Cyclosporine A; Intestinal drug permeability; Medium chain glycerides; Rat single pass intestinal perfusion technique

Indexed keywords

ACYLGLYCEROL; ARLACEL 186; CAPMUL GMO; CAPTEX 350; CYCLOSPORIN A; DECANOIC ACID; FATTY ACID; GLYCEROL OLEATE; HEXANOIC ACID; LAURIC ACID; LINOLEIC ACID; LINOLENIC ACID; MEDIUM CHAIN FATTY ACID; MYRISTIC ACID; OCTANOIC ACID; OLEIC ACID; PALMITIC ACID; STEARIC ACID; TRIOCTANOIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG PENETRATION; ESTERIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ILEUM; INTESTINE ABSORPTION; INTESTINE PERFUSION; MALE; MESENTERIC VEIN; MICELLE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; VISCOMETER;

ANIMALS; CYCLOSPORINE; GLYCERIDES; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; MALE; MESENTERIC VEINS; MODELS, ANIMAL; RATS; RATS, WISTAR;

EID: 21744435553     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567201054368011     Document Type: Article

References (22)

1. Vonderscher, J.; Meinzer, A. Transplant. Proc. 1994, 26(5), 2925-7.
2. Kolars, J.; Awni, A.; Merion, R.; Waltrins, P. Lancet 1991, 338(8781), 1488-90.
3. Drewe, J.; Beglinger, C. and Kissel, T. Br. J. Clin. Pharmac. 1992, 33, 39-43.
4. Constantinides, P.; Scalart, J.; Lancaster, C.; Marcello, J.; Marks, G.; Ellens, H.; Smith, P. Pharm. Research 1994, 11(10), 1385-1390.
5. Muranishi, S. Crit. Rev. Ther. Drug Carrier Syst. 1990, 7(1), 1-33.
6. Chayapathy, I.; Piysh, G. and Arvind, K. AAPS PharmSciTech. 2003, 4(2) Article 16.
7. Stewart, B.; Chan, O.; Lu, R.; Reyner, E.; Schmid, H.; Hamilton, H.; Steinbaugh, B.; Taylor, M. Pharm. Res. 1995, 12(5), 693-699.
8. Grassi, M.; Gadelli, G. Int. J. Pharm. 2001, 299, 95-105.
9. Salphati, L.; Childers, K.; Pan, L.; Tsutsui, K.; Takahashi, L. J. Pharm. Pharmacol. 2001, 53, 1007-1013.
10. Singhal, D.; Ho, N. F.; Andersen, B. J. Pharm. Sci. 1998, 87(5), 569-577.
11. Ho, N. F.; Park, J.; Ni, P.; Higuchi, W. In Animal Models for Oral Drug Delivery in Man in situ and in vivo Approaches, W. Crouthamel.; A.C. Sarapu, Ed. AphA Acad. Pharm. Sci., Washington, DC., 1983, pp. 27-59.
12. Fagerholm, U. and Lennernas, H. Eur. J. Pharm. Sci. 1995, 3, 247-253.
13. Lennernas, H.; Ahrenstedt, O.; Hallgren, R.; Knutson, L.; Ryde, M.; Paalzow, L. Pharm. Res. 1992, 9, 1243-1251.
14. Amelsberg, A. ; Schreingart, C.; Stein, J. ; Simmonds, W.; Sawada, G.; Ho, N. F. Hofmann, A. Am. J. Physiol. 1997, 272(3 pt 1), G498-506.
15. Ho, N. F.; Burton, P.; Conrade, R.; Barsuhn, C. J. Pharm. Sci. 1995, 84(1), 21-27.
16. Ho, N. F. Adv. Drug Del Rev. 1993, 12, 61-97.
17. Komiya, I.; Park, J.; Kamani, A.; Ho, N. F.; Higuchi, W. Int. J. Pharm. 1980, 4, 249-262.
18. Koga, K.; Kawashima, S.; Murakami, M. Eur. J. Pharm. Biopharm. 2002, 54 (3), 311-8.
19. Koga, K.; Murakami, M.; Kawashima, S. Biol: Pharm. Bull. 1999, 22(1), 103-106.
20. Leuug, R.; Shah, D. In Controlled release of drugs: Polymers and aggregate systems, M. Rossof, Ed.; VCH Publishers, New York. 1989, pp. 185-215.
21. Myers, R.A. and Stella, V.J. Int. J. Pharm. 1992, 78, 217-226.
22. Ritschel W. Clin Transplant. 1996, 10, 364-373.